Federal Policy
Latest
- Federal Policy
White House Posts Fraud Ledger Tracking Task Force Findings Since January 2025
The White House has published a Fraud Ledger documenting fraud, waste, and corruption identified by a presidential task force established by executive order in March 2025. The task force is chaired by the Vice President and includes representatives from 11 federal agencies. The ledger serves as a public record of enforcement and recovery actions across federal programs. The article itself fact-checks the ledger's claims, though the specific findings and their application to Medicaid programs are not detailed in the excerpt provided.
- Federal Policy · MO
CMS Awards $45 Million to Missouri Rural Hospitals for Infrastructure and Telehealth
CMS announced over $45 million in federal funding to support rural hospitals in Missouri for facility upgrades, telehealth services including psychiatric and maternal care consultations, and emergency medical services workforce training. The awards are part of broader federal rural health investment programs. Implementation timelines and specific facility allocations were not detailed in the announcement. The funding addresses critical access hospital infrastructure needs and care access gaps in rural Missouri communities.
- Federal Policy
CMS Proposed Rule on SNF Deregulation Under OMB Review
A proposed CMS rule affecting Medicare-participating skilled nursing facilities is under review by the Office of Management and Budget. The proposal appears aligned with prior CMS deregulatory efforts under the Trump administration. OMB review is the final step before a proposed rule is published in the Federal Register, after which a public comment period typically follows. The timing and scope of the proposal remain uncertain pending OMB clearance.
- Federal Policy
White House Drug Affordability Plan May Exclude Key Medications from Medicaid Cost Controls
The Trump administration has released a plan intended to reduce drug costs for Medicaid beneficiaries, but the policy contains an exception that may exempt certain medications from cost controls. The exception could allow manufacturers to avoid pricing restrictions that would otherwise apply to Medicaid drugs. The policy's structure may create differential treatment across drug classes, with potential financial implications for state Medicaid programs and health plans managing pharmacy benefits. Details on implementation timeline and which specific medications qualify for the exception remain to be clarified.
- Federal Policy
Trump Administration Terminates ACA Coverage for 750K Enrollees Citing Fraud
The Trump administration announced Tuesday it will terminate Affordable Care Act marketplace coverage for approximately 750,000 enrollees identified as fraudulent, according to Vice President Vance. The administration estimates the cancellations will save $2.2 billion in federal subsidies. CMS Administrator Dr. Mehmet Oz stated the terminated enrollments represent non-existent individuals. The announcement did not specify an effective date for the terminations or detail the criteria used to identify fraudulent enrollment.

- Federal Policy
CMS Guidance Addresses Medicaid Immigrant Eligibility Restrictions Effective October 1, 2026
The 2025 reconciliation law imposed new Medicaid and CHIP eligibility restrictions for many lawfully present immigrants, with an effective date of October 1, 2026. CMS has issued implementation guidance addressing how states should apply these restrictions. The brief examines operational issues states will face in implementing the new eligibility rules and the impact on affected immigrant populations. The changes directly affect state eligibility systems, enrollment processes, and coverage for lawfully present immigrants who previously qualified for Medicaid and CHIP.
- Federal Policy
CMS Proposes RAPID Pathway to Accelerate Medicare Coverage for FDA-Approved Devices
CMS proposed the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway to coordinate FDA device approval with Medicare coverage decisions, compressing a typical five-year lag to 60-90 days. The pathway synchronizes regulatory approval and coverage determination processes from the outset. Manufacturers of breakthrough devices would participate in joint FDA-CMS reviews. This matters for Medicaid managed care organizations and state agencies because accelerated Medicare coverage pathways often influence state Medicaid coverage decisions and MCO formulary policies for medical devices and durable medical equipment.
- Federal Policy
GOP Health Policy Expert Defends $1 Trillion Medicaid Cut Proposal
An influential Republican health policy expert is defending proposed $1 trillion cuts to Medicaid spending and identifying additional policy targets for future action. The article does not specify which Republican expert or what legislative vehicle would implement these cuts. The timing and likelihood of enactment are unclear given the need for congressional approval. For state Medicaid agencies and managed care organizations, these proposals signal continued federal-level debate over Medicaid financing that could affect coverage levels, eligibility, and capitation payments if enacted.
- Federal Policy
AHA Urges CMS to Limit Retrospective Reconciliation in Medicaid Provider Tax Rule
The American Hospital Association submitted comments September 21 on CMS's proposed rule implementing Medicaid provider tax changes from the July 2025 reconciliation law. Beginning in fiscal year 2027, states cannot raise the provider tax indirect hold harmless threshold above the rate in place at enactment; for expansion states, the hospital threshold decreases 0.5 percentage points annually starting FY 2028. AHA opposes CMS's proposed retrospective reconciliation requirement, arguing it creates unpredictability for state Medicaid programs and adds administrative burden. AHA recommends CMS use prospective estimates for ongoing compliance monitoring and limit retrospective calculations to the one-time statutory threshold determination.
- Federal Policy
MACPAC Comments on CMS Proposed Rule to Revise Health Care Tax Safe Harbor Threshold
The Medicaid and CHIP Payment and Access Commission (MACPAC) submitted comments to CMS on a proposed rule that would revise the indirect hold harmless threshold — the safe harbor — used to determine whether health care-related taxes impermissibly shift Medicaid costs to the federal government. The proposed rule changes how CMS evaluates whether provider tax arrangements violate federal Medicaid financing requirements. This affects state Medicaid financing strategies that rely on provider taxes to fund non-federal share of payments, a common mechanism used by states to draw down federal matching funds.
- Federal Policy
Senators Reintroduce Bill Setting Federal Cybersecurity Standards for Hospitals
Sens. Mark Warner (D-Va.) and Ron Wyden (D-Ore.) reintroduced the Health Infrastructure Security and Accountability Act on September 17, 2026. The legislation would establish minimum federal cybersecurity standards for healthcare organizations and allocate $1.3 billion to help hospitals strengthen their defenses. The bill sets mandatory cybersecurity requirements for healthcare providers, addressing vulnerabilities exposed by recent ransomware attacks on hospital systems. If enacted, it would affect all hospitals and potentially apply to Medicaid providers serving beneficiaries through fee-for-service or managed care arrangements.
- Federal Policy
KFF Brief: 28.5 Million U.S. Residents Have Limited English Proficiency, Face Coverage Gaps
A KFF issue brief published in September 2026 reports that 28.5 million people ages five and older in the U.S. have limited English proficiency (LEP) as of 2024. The brief documents that individuals with LEP experience disproportionate gaps in health insurance coverage and poorer health outcomes due to language access barriers. Because people of color are more likely than White individuals to have LEP, these barriers amplify racial and ethnic health disparities. The brief provides an overview of coverage and care patterns for this population.
- Federal Policy
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf) on September 17, 2026, as the first treatment for mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A) in pediatric patients. Fayuvi is a one-time intravenous gene therapy using adeno-associated virus serotype 9 to deliver a functional SGSH gene. The approval provides a treatment option for a rare pediatric genetic disease previously without FDA-approved therapies. State Medicaid programs and managed care plans will need to determine coverage and reimbursement policies for this specialty gene therapy.
- Federal Policy
Trump Administration Launches Drug Pricing Initiative for State Medicaid Programs
The Trump administration announced a new federal initiative to offer discounted pharmaceuticals to state Medicaid programs, with reported participation from all states. The program, referred to as GENEROUS, aims to reduce prescription drug costs for Medicaid enrollees. Key operational details including pricing mechanisms, implementation timelines, and specific drug categories covered remain undisclosed. The initiative represents a federal effort to lower pharmaceutical spending in Medicaid, though states and managed care organizations await guidance on program structure and participation requirements.
- Federal Policy
All States Apply for CMS Medicaid Drug Pricing Program
All 50 states, Washington, D.C., and Puerto Rico have applied to participate in a CMS arrangement designed to reduce Medicaid drug costs, with 40 states and Puerto Rico already signing agreements. President Trump announced the milestone Friday, characterizing the program as delivering significant savings to state Medicaid programs. The timing and specific mechanics of the drug pricing arrangement were not detailed in the announcement. The development signals broad state interest in federal cost-containment tools for Medicaid pharmacy spending.

- Federal Policy
CMS Launches Medicaid Drug Payment Model with Participating States
CMS announced participating states in a new Medicaid drug payment model aimed at reducing prescription drug costs for Medicaid beneficiaries. The model will test alternative reimbursement methodologies for prescription drugs in Medicaid programs. Participating states will implement the model beginning in 2027, with CMS providing technical assistance and evaluating outcomes over a multi-year period. The initiative targets cost reduction while maintaining access to necessary medications for Medicaid enrollees.
- Federal Policy
Law Firm Comments on CMS Proposed Rule for Remote Monitoring Payment Under 2027 Physician Fee Schedule
Epstein Becker Green submitted comments to CMS on September 14, 2026, regarding the 2027 Physician Fee Schedule Proposed Rule, focusing on payment and coverage policies for device-enabled remote monitoring services furnished to Medicare beneficiaries. The comments were submitted on behalf of health care practices providing these services. The Proposed Rule affects Medicare Part B payment rates and policies that will take effect in calendar year 2027, with the comment period having closed in mid-September 2026.
- Federal Policy · KS
Kansas Receives $16.8M Federal Grant for Rural Health Tech and Transport
Kansas will receive $16.8 million in federal funding to expand telehealth, AI diagnostic tools, and patient transportation in rural areas. The funds are part of CMS's $50 billion Rural Health Transformation Program enacted in 2025, distributed across 14 organizations with $16.2 million for technology modernization and $780,000 for transportation coordination. The program was authorized through the One, Big Beautiful Bill Act, which also included $930 billion in Medicaid cuts over ten years.

- Federal Policy
Georgetown CCF Submits Comments on HHS Vaccination Policy RFI
The Georgetown University Center for Children and Families submitted comments to HHS responding to a Request for Information on federal vaccine recommendation categories and the role of shared clinical decision-making. The comments address how federal vaccination guidance affects clinical practice and policy implementation. The RFI reflects HHS consideration of potential changes to how vaccine recommendations are categorized and communicated to providers and patients. For Medicaid programs, this matters because federal vaccine recommendations drive EPSDT coverage requirements and Early and Periodic Screening, Diagnostic and Treatment mandates for children.
- Federal Policy
Census Bureau Releases 2025 Child Uninsured Data; ACS Release Delayed
The U.S. Census Bureau released Current Population Survey data for calendar year 2025 examining child uninsured rates, poverty, income, and health insurance trends. The American Community Survey, which typically releases simultaneously and provides larger sample sizes for state-level analysis, has not yet been published. The delay in ACS data limits the ability to conduct granular state and sub-state analysis of coverage trends. For state Medicaid agencies and advocates tracking coverage following recent policy changes, the absence of robust state-level data complicates assessment of enrollment shifts and children's coverage losses.